Discover, Control & Prevent diabetic risk.
How does MDDiabeticPro differ from other diabetes tests?
PMLS offers a variety of biomarkers on our diabetes test panel. Besides running a normal A1C test, PMLS goes further and tests a patient’s Fasting Glucose, GlycoMark, Adiponectin, Leptin, HOMA-IR, Insulin, and C-peptide, but we don’t stop there. To give patient’s a look at the bigger picture, we also run a Comorbidity Assessment of Cardiovascular and Renal biomarkers, as well as a Genetic Predisposition test called DIABETESpredict™. With DIABETESpredict™, doctors can help their patients know their risk for type 2 diabetes earlier.
MdDiabeticPro is also specifically designed to help Type 1 diabetes patients with the management of the disease. This test can be used for monitoring individuals who are pre-disposed to insulin resistance. The results of the test equip physicians with the information needed to fine tune nutrition and exercise plans, helping a T1D patient to make the use of insulin most effective.
Know your risk with DIABETESPredict™
DIABETESpredict™ is a genotyping tool for type 2 diabetes risk assessment. It analyzes the main genetic variants associated with T2D, taking into account multi-ethnic associations. DIABETESpredict™ identifies high risk individuals and gives them additional information to implement lifestyle changes. Early identification of type 2 diabetes enables prevention and with DIABETESpredict™ doctors are empowered to help their patients further.
500 Million worldwide suffer
34.2 Million Americans, or 10.5% of the population, had diabetes.
We want to hear from you! Tell us more about your interest in MDChemistryPro today.
Read Our Blog
Premier Medical Laboratories Sponsors Greenville Triumph & Liberty Soccer Clubs
Premier Medical laboratories- Greenville, South Carolina- Premier Medical Laboratory Services (PMLS), an operating division of Diversified Medical Healthcare is pleased to announce its continued support of the Greenville Triumph and Greenville Liberty Soccer Clubs as...
Premier Medical Laboratory Services Updates Test Offerings to Better Care for Patients
Premier Medical Laboratory Services (PMLS) announces updates to two of their testing options, MDHeartPro, a panel that detects cardiovascular disease early by looking into more advanced biomarkers, and MDGeneticPro GI, which identifies several disease-causing viruses,...
Respiratory Infections: The Important Role of Diagnostic Laboratory Testing
PCR testing for the detection of respiratory infections like influenza, COVID-19, and the RSV Virus is a vital tool in the fight against antibiotic resistance. The development of antibiotic resistance is one of the most important challenges facing the medical...
Breast Cancer Awareness Month
Breast cancer is the second most common cancer among women in the U.S. This year, an estimated 290,000 new cases of invasive breast cancer will be diagnosed in women. Although this is an alarming number, breast cancer is a highly treatable disease, and early detection...
World Heart Day: The Relevance of Cardiovascular Disease Symptoms
Dive Deeper into Your Patients’ Cardiac Health Cardiovascular Disease (CVD) is the world's leading cause of death claiming 18.6 million lives each year. World Heart Day highlights actions individuals can take to prevent and control CVD. Our goal is also to provide...
PMLS Receiving NY State Accreditation Mentioned in GenomeWeb Article